Evidence map›Paper›PMID 40506707›Full record

ArticleHarm reduction journal2025

Using RE-AIM to evaluate the implementation of a social marketing and free product distribution project for fentanyl and xylazine test strips in New York State.

Hilary M Kirk, Joshua J Lynch, Kimberly A Bernosky, Orian B Painter, Shelby Arena, Mia Dickinson, Lyudmila Pakhomova, Brian M Clemency

Abstract read
In one paragraph

Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hilary M KirkDepartment of Emergency Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, University at Buffalo Gateway Building, Suite 420, 77 Goodell St., Buffalo, NY, 14203, USA. hilaryki@buffalo.edu.ORCID 0009-0003-9464-2863
Joshua J LynchDepartment of Emergency Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, University at Buffalo Gateway Building, Suite 420, 77 Goodell St., Buffalo, NY, 14203, USA.ORCID 0000-0001-5134-8662
Kimberly A BernoskyDepartment of Community Health and Health Behavior in the School of Public Health and Health Professions, University at Buffalo, 3435 Main St, NY, 14215, Buffalo, USA.ORCID 0000-0002-7843-6432
Orian B PainterDepartment of Community Health and Health Behavior in the School of Public Health and Health Professions, University at Buffalo, 3435 Main St, NY, 14215, Buffalo, USA.ORCID 0009-0005-5783-1782
Shelby ArenaDepartment of Emergency Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, University at Buffalo Gateway Building, Suite 420, 77 Goodell St., Buffalo, NY, 14203, USA.ORCID 0009-0002-2121-6903
Mia DickinsonDepartment of Emergency Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, University at Buffalo Gateway Building, Suite 420, 77 Goodell St., Buffalo, NY, 14203, USA.
Lyudmila PakhomovaDepartment of Emergency Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, University at Buffalo Gateway Building, Suite 420, 77 Goodell St., Buffalo, NY, 14203, USA.
Brian M ClemencyDepartment of Community Health and Health Behavior in the School of Public Health and Health Professions, University at Buffalo, 3435 Main St, NY, 14215, Buffalo, USA.ORCID 0000-0002-7610-3087

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDrug test strips can be used to check for the presence of contaminants, such as fentanyl and xylazine in a person’s drug supply. In 2022, New York State began a media campaign and free drug test strip distribution effort throughout the state to raise awareness of adulterated drugs, help people who use drugs make safer choices, and ultimately prevent overdoses.

methodsUtilizing the RE-AIM Framework, the objective of this study was to conduct a process evaluation of the implementation of this project and discuss lessons learned to help inform future distribution and media campaigns. The study team utilized operational, public health, and census data to identify specific trends to inform metrics for each construct of RE-AIM. A retrospective analysis was conducted using 22 months of operational data including logistical data and marketing information.

resultsThe demand for test strips increased in association with the release of campaigns. The most populous counties in the State were not always associated with the highest concentration of demand. A correlation analysis between county overdose death rates and county orders for test strips indicated a weak positive association (r = 0.0014) which was statistically significant (p =.05). By the end of the 22-month analysis, all counties in the State had adopted the intervention and based on this success the program is now expanding to other methods of dispensation to reach more vulnerable populations.

conclusionsMass media campaigns with free product distribution can be effective public health promotion strategies, particularly in acute circumstances. Our evaluation demonstrates an implementation experience for public health practitioners considering similar efforts.

Indexed as

Drug ContaminationFentanylSocial MarketingXylazineDrug OverdoseHumansNew YorkRetrospective StudiesFentanylXylazineFentanylHarm reductionOverdoseProduct distributionPublic healthRE-AIM implementationSocial marketingXylazine

Identifiers

PMID40506707
PMCPMC12164095

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.